Frequent overexpression of PDK1 in primary nasopharyngeal carcinoma is associated with poor prognosis.

[1]  D. Goldstein,et al.  Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature , 2016, Journal of Clinical Immunology.

[2]  N. Lee,et al.  Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma. , 2016, Oral oncology.

[3]  J. Pignon,et al.  Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies. , 2015, Hematology/oncology clinics of North America.

[4]  T. Taguchi,et al.  Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma. , 2015, Anticancer research.

[5]  L. Primo,et al.  PDK1: A signaling hub for cell migration and tumor invasion. , 2015, Biochimica et biophysica acta.

[6]  Jin Chen,et al.  Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis , 2015, OncoTargets and therapy.

[7]  S. Leung,et al.  PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer. , 2015, Cell metabolism.

[8]  G. Klein,et al.  Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells , 2015, PloS one.

[9]  Xiangjian Luo,et al.  The role of targeting kinase activity by natural products in cancer chemoprevention and chemotherapy (Review). , 2015, Oncology reports.

[10]  Lei Han,et al.  Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro , 2014, Medical Oncology.

[11]  A. Puliafito,et al.  PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction , 2014, The Journal of cell biology.

[12]  M. Falasca,et al.  Cancer Management and Research Dovepress 3-phosphoinositide-dependent Protein Kinase-1 as an Emerging Target in the Management of Breast Cancer , 2022 .

[13]  Gwang Lee,et al.  Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target , 2012, International journal of oncology.

[14]  K. Miller,et al.  Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC) , 2013, World Journal of Urology.

[15]  T. Janvilisri,et al.  Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular Biomarkers , 2012, International journal of cell biology.

[16]  Kui-Sheng Chen,et al.  Silencing of PDK1 gene expression by RNA interference suppresses growth of esophageal cancer. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[17]  A. Earnest,et al.  Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence , 2012, BMC Cancer.

[18]  M. Falasca,et al.  Targeting PDK1 in cancer. , 2011, Current medicinal chemistry.

[19]  Jiansheng Li,et al.  Epigenetic Silencing of MicroRNA-375 Regulates PDK1 Expression in Esophageal Cancer , 2011, Digestive Diseases and Sciences.

[20]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[21]  K. Wei,et al.  Histopathological classification of nasopharyngeal carcinoma. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[22]  D. Alessi,et al.  The nuts and bolts of AGC protein kinases , 2010, Nature Reviews Molecular Cell Biology.

[23]  Y. Liu,et al.  Down-Regulation of 3-Phosphoinositide–Dependent Protein Kinase-1 Levels Inhibits Migration and Experimental Metastasis of Human Breast Cancer Cells , 2009, Molecular Cancer Research.

[24]  A. Giatromanolaki,et al.  PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer , 2008, British Journal of Cancer.